Form 4 for INM InMed Pharmaceuticals Inc.
Accepted 2022-01-06 00:00:00 ET · period of report 2022-01-06 · accession 0001213900-22-001005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-06 | 2022-01-06 | INM | Johnson Shane Aaron | SVP, GM of BayMedica LLC | P - Purchase | $1.26 | +8,500 | 304.6K | +3% | +$10.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-06 | P | A | 8,500 | $1.26 | 304,595 | D | — | — |